Bioxytran BIXT
OTC BIXT
$0.02 +0.00 (+0.00%)
At close: Sep 29, 2026 · 4:00 PM EDT

Bioxytran (BIXT) Non Operating Interest Expenses (2010 - 2026)

Updated

Bioxytran (BIXT) reported Non Operating Interest Expenses of $36,126 for Q2 2026, up 20.0% from $30,112 a year earlier and up 1.1% from the prior quarter.

Analysis

Bioxytran (BIXT) Non Operating Interest Expenses (2010 - 2026) Analysis & Trends

Over the twelve months ended Jun 30, 2026, Bioxytran's Non Operating Interest Expenses came in at $144,900, up 45.8% year-over-year; for FY2025, it came in at $134,314, up 59.4% from FY2024.

  • Non Operating Interest Expenses has a five-year compound annual growth rate of -33.3% (FY2020 to FY2025).
  • By year, Non Operating Interest Expenses came in at $84,240 in FY2024 (-56.4%), $193,191 in FY2023 and $2.02 million in FY2021 (+99.1%).
  • Five-year quarterly Non Operating Interest Expenses spans a low of $17,845 in Q3 2024 and a high of $1.82 million in Q4 2021.
  • Year over year, Non Operating Interest Expenses has now increased in each of the last six quarters, with growth averaging 48.3% over the last six quarters.
  • The high point for year-over-year Non Operating Interest Expenses in five years was Q3 2025 (growth of 104.7%); the low point was Q3 2021 (a decline of 62.5%).
  • Per Business Quant data, the three quarters before Q2 2026 came in at $35,729 (Q1 2026), $36,523 (Q4 2025) and $36,522 (Q3 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Non Operating Interest Expenses (Qtr)
1 Johnson & Johnson 638.12 Bn 556.64 Bn 17.26 Bn 281.00 Mn
2 AbbVie 462.60 Bn 435.75 Bn 12.70 Bn -
3 Merck 358.70 Bn 313.13 Bn 12.21 Bn -
4 Novartis Ag 272.16 Bn 228.03 Bn 11.24 Bn -462.00 Mn
5 Astrazeneca 250.36 Bn 223.92 Bn 12.86 Bn -435.00 Mn
6 Amgen 227.87 Bn 183.27 Bn 7.24 Bn 673.00 Mn
7 Gilead Sciences 184.97 Bn 159.08 Bn 6.22 Bn 247.00 Mn
8 Pfizer 162.61 Bn 109.56 Bn 10.94 Bn -
9 Vertex Pharmaceuticals 132.45 Bn 104.46 Bn 2.84 Bn -
10 Bioxytran 2.29 Mn 1.13 Mn - 36,126.00
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 36,126.00
Mar 31, 2026 35,729.00
Dec 31, 2025 36,523.00
Sep 30, 2025 36,522.00
Jun 30, 2025 30,112.00
Mar 31, 2025 31,157.00
Dec 31, 2024 20,290.00
Sep 30, 2024 17,845.00
Jun 30, 2024 19,731.00
Mar 31, 2024 26,374.00
Mar 31, 2022 52,035.00
Dec 31, 2021 1.82 Mn
Sep 30, 2021 32,475.00
Jun 30, 2021 84,217.00
Mar 31, 2021 87,410.00
Dec 31, 2020 95,092.00
Sep 30, 2020 86,593.00
Jun 30, 2020 740,424.00
Mar 31, 2020 107,730.00
Dec 31, 2019 14,954.00
API Access

Bioxytran Non Operating Interest Expenses API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=non-operating-interest-expenses&ticker=BIXT&period=max&api_key=YOUR_API_KEY